**6. Role of PPARβ/δ in insulin resistance**

As stated above insulin resistance plays a crucial role in the development of hypertrigliceridemia, resulting in a sequence of lipoprotein changes leading to atherogenic dyslipidemia. Thus, those drugs, such as the PPARβ/δ ligands, which improve insulin resistance may also contribute to ameliorate the atherogenic dyslipidemia.
